Venetoclax combined with azacitidine in blastic plasmacytoid dendritic cell neoplasm: a case report and comprehensive review on the current and future treatment.

MLA

Wang, Xiaoning, et al. “Venetoclax Combined with Azacitidine in Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report and Comprehensive Review on the Current and Future Treatment.” Frontiers in Medicine, vol. 11, July 2024, p. 1425833. EBSCOhost, https://doi.org/10.3389/fmed.2024.1425833.

APA

Wang, X., Guo, J., Liu, Y., Zheng, N., Xu, S., Wu, L., Yuan, R., Xue, L., & Li, J. (2024). Venetoclax combined with azacitidine in blastic plasmacytoid dendritic cell neoplasm: a case report and comprehensive review on the current and future treatment. Frontiers in Medicine, 11, 1425833. https://doi.org/10.3389/fmed.2024.1425833

Chicago

Wang, Xiaoning, Jiashuo Guo, Yan Liu, Na Zheng, Shaohan Xu, Lianhui Wu, Ruirui Yuan, Liying Xue, and Jie Li. 2024. “Venetoclax Combined with Azacitidine in Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report and Comprehensive Review on the Current and Future Treatment.” Frontiers in Medicine 11 (July): 1425833. doi:10.3389/fmed.2024.1425833.